
Chronic glucocorticoid exposure, even at low doses, is now seen by regulators and clinicians as an unacceptable safety burden. Sponsors that prioritize steroid-toxicity from the outset position ...
Despite decades of widespread use, steroids are facing a growing backlash. Leading researchers and sponsors are aligning on a new imperative: quantify the harm. A flurry of guidance, tools, and ...